These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17145775)

  • 1. Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk.
    van Herwaarden AE; Wagenaar E; Merino G; Jonker JW; Rosing H; Beijnen JH; Schinkel AH
    Mol Cell Biol; 2007 Feb; 27(4):1247-53. PubMed ID: 17145775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.
    van Herwaarden AE; Wagenaar E; Karnekamp B; Merino G; Jonker JW; Schinkel AH
    Carcinogenesis; 2006 Jan; 27(1):123-30. PubMed ID: 16000399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion.
    Merino G; Alvarez AI; Pulido MM; Molina AJ; Schinkel AH; Prieto JG
    Drug Metab Dispos; 2006 Apr; 34(4):690-5. PubMed ID: 16434544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.
    Jonker JW; Merino G; Musters S; van Herwaarden AE; Bolscher E; Wagenaar E; Mesman E; Dale TC; Schinkel AH
    Nat Med; 2005 Feb; 11(2):127-9. PubMed ID: 15685169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
    Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep.
    Pulido MM; Molina AJ; Merino G; Mendoza G; Prieto JG; Alvarez AI
    J Vet Pharmacol Ther; 2006 Aug; 29(4):279-87. PubMed ID: 16846465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.
    Vlaming ML; Lagas JS; Schinkel AH
    Adv Drug Deliv Rev; 2009 Jan; 61(1):14-25. PubMed ID: 19118589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    van Herwaarden AE; Jonker JW; Wagenaar E; Brinkhuis RF; Schellens JH; Beijnen JH; Schinkel AH
    Cancer Res; 2003 Oct; 63(19):6447-52. PubMed ID: 14559835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bovine ABCG2 polymorphism Y581S SNP on secretion into milk of enterolactone, riboflavin and uric acid.
    Otero JA; Miguel V; González-Lobato L; García-Villalba R; Espín JC; Prieto JG; Merino G; Álvarez AI
    Animal; 2016 Feb; 10(2):238-47. PubMed ID: 26510964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).
    Merino G; Jonker JW; Wagenaar E; Pulido MM; Molina AJ; Alvarez AI; Schinkel AH
    Drug Metab Dispos; 2005 May; 33(5):614-8. PubMed ID: 15703302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
    Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
    Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin.
    Real R; Egido E; Pérez M; González-Lobato L; Barrera B; Prieto JG; Alvarez AI; Merino G
    J Vet Pharmacol Ther; 2011 Aug; 34(4):313-21. PubMed ID: 20950350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model of secreting murine mammary epithelial HC11 cells comprising endogenous Bcrp/Abcg2 expression and function.
    Tallkvist J; Yagdiran Y; Danielsson L; Oskarsson A
    Cell Biol Toxicol; 2015 Apr; 31(2):111-20. PubMed ID: 25791223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins.
    van Herwaarden AE; Schinkel AH
    Trends Pharmacol Sci; 2006 Jan; 27(1):10-6. PubMed ID: 16337280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo interaction of moxidectin with BCRP/ABCG2.
    Perez M; Blazquez AG; Real R; Mendoza G; Prieto JG; Merino G; Alvarez AI
    Chem Biol Interact; 2009 Jun; 180(1):106-12. PubMed ID: 19428349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
    Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH
    Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
    Breedveld P; Zelcer N; Pluim D; Sönmezer O; Tibben MM; Beijnen JH; Schinkel AH; van Tellingen O; Borst P; Schellens JH
    Cancer Res; 2004 Aug; 64(16):5804-11. PubMed ID: 15313923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).
    Meyer zu Schwabedissen HE; Kroemer HK
    Handb Exp Pharmacol; 2011; (201):325-71. PubMed ID: 21103975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).
    González-Sarrías A; Miguel V; Merino G; Lucas R; Morales JC; Tomás-Barberán F; Alvarez AI; Espín JC
    J Agric Food Chem; 2013 May; 61(18):4352-9. PubMed ID: 23586460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.